These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
401 related articles for article (PubMed ID: 19207861)
21. Luminex technology for anti-HLA antibody screening: evaluation of performance and of impact on laboratory routine. Colombo MB; Haworth SE; Poli F; Nocco A; Puglisi G; Innocente A; Serafini M; Messa P; Scalamogna M Cytometry B Clin Cytom; 2007 Nov; 72(6):465-71. PubMed ID: 17397064 [TBL] [Abstract][Full Text] [Related]
22. Living donor renal transplantation in the presence of donor-specific human leukocyte antigen antibody detected by solid-phase assay. Phelan D; Mohanakumar T; Ramachandran S; Jendrisak MD Hum Immunol; 2009 Aug; 70(8):584-8. PubMed ID: 19477211 [TBL] [Abstract][Full Text] [Related]
23. Anti-HLA alloantibodies in pediatric solid organ transplantation. Girnita AL; Webber SA; Zeevi A Pediatr Transplant; 2006 Mar; 10(2):146-53. PubMed ID: 16573598 [TBL] [Abstract][Full Text] [Related]
24. Emerging role of donor-specific anti-human leukocyte antigen antibody determination for clinical management after solid organ transplantation. Zeevi A; Lunz JG; Shapiro R; Randhawa P; Mazariegos G; Webber S; Girnita A Hum Immunol; 2009 Aug; 70(8):645-50. PubMed ID: 19527760 [TBL] [Abstract][Full Text] [Related]
25. Simultaneous detection of antibody binding and cytotoxicity in flow cytometry crossmatch for renal transplantation. Won DI; Jeong HD; Kim YL; Suh JS Cytometry B Clin Cytom; 2006 Mar; 70(2):82-90. PubMed ID: 16470535 [TBL] [Abstract][Full Text] [Related]
26. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation. Lee PC; Ozawa M; Hung CJ; Lin YJ; Chang SS; Chou TC Transplant Proc; 2009; 41(1):95-8. PubMed ID: 19249487 [TBL] [Abstract][Full Text] [Related]
27. Pre-formed donor-specific alloantibodies (DSA) detected only by luminex technology using HLA-coated microspheres and causing acute humoral rejection and kidney graft dysfunction. Muro M; Llorente S; Gónzalez-Soriano MJ; Minguela A; Gimeno L; Alvarez-López MR Clin Transpl; 2006; ():379-83. PubMed ID: 18365392 [TBL] [Abstract][Full Text] [Related]
28. Which human leukocyte antigen antibodies are really clinically relevant? Opelz G; Claas FH Hum Immunol; 2009 Aug; 70(8):561-2. PubMed ID: 19580832 [No Abstract] [Full Text] [Related]
29. Pre- and posttransplant monitoring of alloantibodies by complement-dependent cytotoxicity and luminex methodologies in liver transplantation. Monteiro F; Rodrigues H; Kalil J; Castro MC; Panajotopoulos N; Paredes M; Massarolo P; Mies S Transplant Proc; 2012 Oct; 44(8):2411-2. PubMed ID: 23026608 [TBL] [Abstract][Full Text] [Related]
30. Current methodologies for detecting sensitization to HLA antigens. Cecka JM Curr Opin Organ Transplant; 2011 Aug; 16(4):398-403. PubMed ID: 21666477 [TBL] [Abstract][Full Text] [Related]
31. A rapid flow cytometry assay for HLA antibody detection using a pooled cell panel covering 14 serological crossreacting groups. Shroyer TW; Deierhoi MH; Mink CA; Cagle LR; Hudson SL; Rhea SD; Diethelm AG Transplantation; 1995 Feb; 59(4):626-30. PubMed ID: 7878769 [TBL] [Abstract][Full Text] [Related]
32. The repercussions of implementing flow cytometry as a single HLA antibody screening technique in prospective renal transplant recipients. Magee B; Martin J; Middleton D Transpl Int; 2006 Feb; 19(2):105-9. PubMed ID: 16441358 [TBL] [Abstract][Full Text] [Related]
33. Characterization of anti-HLA antibodies eluted from explanted renal allografts. Heinemann FM; Roth I; Rebmann V; Arnold ML; Spriewald BM; Grosse-Wilde H Clin Transpl; 2006; ():371-8. PubMed ID: 18365391 [TBL] [Abstract][Full Text] [Related]
34. C1q assay for the detection of complement fixing antibody to HLA antigens. Chen G; Tyan DB Methods Mol Biol; 2013; 1034():305-11. PubMed ID: 23775744 [TBL] [Abstract][Full Text] [Related]
35. Flow cytometric detection of complement-activating HLA antibodies. Schönemann C; Lachmann N; Kiesewetter H; Salama A Cytometry B Clin Cytom; 2004 Nov; 62(1):39-45. PubMed ID: 15476206 [TBL] [Abstract][Full Text] [Related]
37. The presence of donor-specific human leukocyte antigen antibodies does not preclude successful withdrawal of tacrolimus in stable renal transplant recipients. Kreijveld E; Hilbrands LB; van Berkel Y; Joosten I; Allebes W Transplantation; 2007 Nov; 84(9):1092-6. PubMed ID: 17998862 [TBL] [Abstract][Full Text] [Related]